­

June 2016

New publication in the prestige “Journal of Arthroplasty” demonstrates that Using an IPCD and TXA and discontinuing enoxaparin and preoperative autologous blood donation eliminated blood transfusion in primary THA and TKA without any increase in VTED. Using an IPCD instead of enoxaparin, adding TXA, and eliminating preoperative autologous donation each had an incremental dose response [...]

June 2016

Activecare® gets additional evidence for its efficiency: New publication in the prestige “Journal of Arthroplasty” Confirming Patient Satisfaction, Safety, Efficacy and Reduction of Hospital Readmissions with ActiveCare® DVT prophylaxis Mobile Compression Device Following Joint Replacement Surgery. This was a prospective study of 3,143 patients undergoing primary or revision knee or hip arthroplasty. Study title: The Effectiveness [...]

November 2015

Following the study presented at the American Association of Hip and Knee Surgeons 25th Annual Meeting that shows ActiveCare® Mobile Compression DVT Prophylaxis Following Total Joint Replacement Surgery Leads To Significant Hospitals Cost Reductions. M.D Richard Iorio talks study on VTE and synchronized mobile compression Watch video

November 2015

Medical Compression Systems Additional good news for #ORTHOPEDIC SURGEONS AND #HOSPITAL ADMINISTRATION: New Study Shows ActiveCare® Mobile Compression DVT Prophylaxis Following Total Joint Replacement Surgery Leads To SIGNIFICANT HOSPITALS COST REDUCTIONS link text

April 2015

Just released: New data further validating the use of the ActiveCare® DVT prophylaxis compression system following total joint replacement procedures. This study, selected as the best poster in the adult reconstruction category, was presented at the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting. You are welcome to read more about it here

March 2015

ActiveCare took part at AAOS 2015 - American Academy of Orthopaedic Surgeons, that took place in Las Vegas, March 25-27. Many TJR surgeons gathered around our booth, learning how to prevent VTE in TJA patients with no major bleeding reported. Visitors at our booth participated in a survey dedicated to learn how TJR surgeons confront the risks of [...]